Clínica Universidad de Navarra (CUN)
Centro clínico de la Universidad de Navarra
University of Michigan–Ann Arbor
Ann Arbor, Estados UnidosPublicaciones en colaboración con investigadores/as de University of Michigan–Ann Arbor (38)
2024
-
A road map for the treatment of pediatric diffuse midline glioma
Cancer Cell
-
Development and external validation of the 'Global Surgical-Site Infection' (GloSSI) predictive model in adult patients undergoing gastrointestinal surgery
British Journal of Surgery, Vol. 111, Núm. 6
-
Highlight selection of radiochemistry and radiopharmacy developments by editorial board
EJNMMI Radiopharmacy and Chemistry, Vol. 9, Núm. 1
2023
-
Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways
Cancer Discovery, Vol. 13, Núm. 11, pp. 2370-2393
-
Highlight selection of radiochemistry and radiopharmacy developments by editorial board
EJNMMI Radiopharmacy and Chemistry, Vol. 8, Núm. 1
2022
-
Identifying FGFR2 fusions/rearrangements in cholangiocarcinoma patients using a novel cfDNA algorithm for treatment with RLY-4008, a highly selective irreversible FGFR2 inhibitor
European Journal of Cancer, Vol. 174, pp. S116
-
Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Prostate Cancer A Patient-Level Data Analysis of 3 Cohorts
JAMA Oncology, Vol. 8, Núm. 3
-
Recent Technical Developments in ASL: A Review of the State of the Art
Magnetic Resonance in Medicine, Vol. 88, Núm. 5, pp. 2021-2042
-
Targeting the EIF2AK1 Signaling Pathway Rescues Red Blood Cell Production in SF3B1-Mutant Myelodysplastic Syndromes With Ringed Sideroblasts
BLOOD CANCER DISCOVERY, Vol. 3, Núm. 6
2021
-
A Real-World Observational Cohort of Patients with Hepatocellular Carcinoma: Design and Rationale for TARGET-HCC
Hepatology Communications, Vol. 5, Núm. 3, pp. 538-547
-
Comparison of Multimodal Therapies and Outcomes among Patients with High-Risk Prostate Cancer with Adverse Clinicopathologic Features
JAMA Network Open, Vol. 4, Núm. 7
-
Correction to: Prevalence, associated factors and outcomes of pressure injuries in adult intensive care unit patients: the DecubICUs study (Intensive Care Medicine, (2021), 47, 2, (160-169), 10.1007/s00134-020-06234-9)
Intensive Care Medicine
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
-
Highlight selection of radiochemistry and radiopharmacy developments by editorial board
EJNMMI Radiopharmacy and Chemistry, Vol. 6, Núm. 1
-
Highlight selection of radiochemistry and radiopharmacy developments by editorial board (January–June 2020)
EJNMMI Radiopharmacy and Chemistry, Vol. 6, Núm. 1
-
Performance of a Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography-Derived Risk-Stratification Tool for High-risk and Very High-risk Prostate Cancer
JAMA Network Open, Vol. 4, Núm. 12, pp. E2138550
-
Pressure injury prediction models for critically-ill patients should consider both the case-mix and local factors
Intensive and Critical Care Nursing
-
Prevalence, associated factors and outcomes of pressure injuries in adult intensive care unit patients: the DecubICUs study
Intensive Care Medicine, Vol. 47, Núm. 2, pp. 160-169
2020
-
A dose-finding Phase 2 study of single agent isatuximab (anti-CD38 mAb) in relapsed/refractory multiple myeloma
Leukemia, Vol. 34, Núm. 12, pp. 3298-3309
-
EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0
European Journal of Nuclear Medicine and Molecular Imaging, Vol. 47, Núm. 8, pp. 1885-1912